Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: VA, California Panels Urge Costly Hepatitis C Drugs For Sickest Patients


Senior Member

Status: Offline
Posts: 380
Date:
RE: VA, California Panels Urge Costly Hepatitis C Drugs For Sickest Patients
Permalink  
 


Tig,

Yeah.. a lot to process. I saw those percentages you mentioned referenced as part of the Pillar 2B trial, which was Simeprevir + Peg/Riba. There were 386 enrolled in that. If you were talking about another section, you'll have to point me to it. I already got a headache. ;)

wayne



__________________

66 y/o male - Geno 1b - F4 cirrhotic dx 2001 - 16 wk treatment w/ Sovaldi/Olysio/Riba - Und @ EOT+24 SVR

 

Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

Hi Wayne,

Thanks for the links. It's going to take awhile to absorb it all, as they are lengthy reads. I have done an initial review of the CTAF report and find it to be very interesting indeed. The rates of success (SVR) in the recent SOC's, Boc and TVR appear to hold a consensus agreement of 1% relapse at SVR12 but it does indicate a reduction in that rate to 2-2.5% past 1 year. I haven't seen that documented before. It will be interesting to see how they came to that conclusion and the number of participants referenced. One thing is certain, organizations like this will continue to have endless opportunities and interest in their findings. I find looking at their resources as a good place to start.

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 



Senior Member

Status: Offline
Posts: 380
Date:
Permalink  
 

"Doctors should consider expensive new hepatitis C drugs for patients with advanced liver disease, including those awaiting transplants, but ask most others to wait for drugs in development, the Department of Veterans Affairs said Wednesday." 

"A California panel made similar recommendations Monday, saying in a report to insurers, providers and consumers that immediate treatment with the new drugs, Sovaldi and Olysio, should be given to those with advanced disease, but could be delayed for others."

Kaiser Health News Article

 



__________________

66 y/o male - Geno 1b - F4 cirrhotic dx 2001 - 16 wk treatment w/ Sovaldi/Olysio/Riba - Und @ EOT+24 SVR

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.